| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.67▼ | 0.67▲ | 0.67▼ | 3.06▼ | 2.93▼ |
| MA10 | 0.67▼ | 0.67▼ | 1.55▼ | 3.41▼ | 2.98▼ |
| MA20 | 0.67▲ | 1.70▼ | 2.60▼ | 3.41▼ | 3.42▼ |
| MA50 | 0.67▲ | 2.88▼ | 3.28▼ | 3.18▼ | 4.92▼ |
| MA100 | 1.32▼ | 3.31▼ | 3.50▼ | 3.54▼ | 8.36▼ |
| MA200 | 2.48▼ | 3.50▼ | 3.37▼ | 4.61▼ | 29.37▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.028▼ | -0.271▼ | -0.208▼ | -0.012▼ |
| RSI | 42.169▼ | 3.825▼ | 3.487▼ | 12.317▼ | 20.268▼ |
| STOCH | 47.268 | 31.164 | 2.407▼ | 27.121 | 63.448 |
| WILL %R | -42.857 | -97.621▼ | -97.719▼ | -97.600▼ | -97.600▼ |
| CCI | 11.975 | -36.529 | -66.742 | -466.667▼ | -312.577▼ |
| RSI | $SITC RSI(14) Crossed Below 50 | Set Alert |
| ▼ RSI | $SITC RSI(14) Crossed Below 30 | Set Alert |
| ▼ MACD | $SITC MACD(12,26,9) Crossed Below Zero | Set Alert |
| MA | $SITC Price Crossed Below MA(50) | Set Alert |
| MA | $SITC Price Crossed Below MA(26) | Set Alert |
| ▼ GAP | $SITC Open Gap Down %5 | Set Alert |
| ▼ GAP | $SITC Open Gap Down %3 | Set Alert |
| ▼ GAP | $SITC Open Gap Down %2 | Set Alert |
| ▼ BREAK | $SITC Price Breaks 60 Days Low | Set Alert |
| ▼ BREAK | $SITC Price Breaks 30 Days Low | Set Alert |
| ▼ BREAK | $SITC Price Breaks 20 Days Low | Set Alert |
| ▼ BREAK | $SITC Price Breaks 10 Days Low | Set Alert |
|
Friday, November 06, 2026 03:19 PM
KING OF PRUSSIA, PA, UNITED STATES, November 6, 2026 /EINPresswire.com/ — Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using ...
|
|
Friday, November 06, 2026 08:01 AM
SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced interim safety and efficacy results from the VICTORIA-01 Phase 1 clinical study of SOT201, a PD-1 ...
|
|
Friday, November 06, 2026 08:01 AM
Modular platform enables dual-antigen targeting to limit tumor escape and performance-enhancing peptide armoring to improve solid tumor control Findings further support the potential of precise, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 0.61 | 0.7329 | 0.59 | 0.668 | 14,904,082 |
| 05/11/26 | 3.71 | 3.745 | 3.57 | 3.57 | 10,339,706 |
| 04/11/26 | 3.70 | 3.74 | 3.55 | 3.72 | 9,897,352 |
| 03/11/26 | 3.67 | 3.71 | 3.645 | 3.67 | 1,781,452 |
| 02/11/26 | 3.73 | 3.7685 | 3.655 | 3.67 | 2,078,829 |
| 30/10/26 | 3.84 | 3.84 | 3.72 | 3.73 | 2,890,097 |
| 29/10/26 | 3.79 | 3.83 | 3.765 | 3.82 | 3,705,859 |
| 28/10/26 | 3.75 | 3.80 | 3.715 | 3.79 | 1,925,690 |
| 27/10/26 | 3.73 | 3.80 | 3.72 | 3.76 | 1,469,456 |
| 26/10/26 | 3.73 | 3.80 | 3.71 | 3.72 | 2,624,878 |
|
|
||||
|
|
||||
|
|